Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Multiple Myeloma × Rituximab × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Dendritic Cell Sarcoma, Interdigitating 1 Anemia 1

Interventions

Dexamethasone 16 daratumumab 9 Bortezomib 9 Lenalidomide 6 pomalidomide 4 carfilzomib 4 isatuximab 3 selinexor 2 Thalidomide 2 Prednisone 2 Melphalan 2 trametinib 1 talquetamab 1 montelukast 1 melflufen 1 idecabtagene vicleucel 1 darlin protein, Dictyostelium 1 dabrafenib 1 belantamab mafodotin 1 L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1 Diphenhydramine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡